These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 18981259
1. Pediatric glioblastomas: a histopathological and molecular genetic study. Suri V, Das P, Pathak P, Jain A, Sharma MC, Borkar SA, Suri A, Gupta D, Sarkar C. Neuro Oncol; 2009 Jun; 11(3):274-80. PubMed ID: 18981259 [Abstract] [Full Text] [Related]
2. Characterization of molecular genetic alterations in GBMs highlights a distinctive molecular profile in young adults. Jha P, Suri V, Singh G, Jha P, Purkait S, Pathak P, Sharma V, Sharma MC, Suri A, Gupta D, Mahapatra AK, Sarkar C. Diagn Mol Pathol; 2011 Dec; 20(4):225-32. PubMed ID: 22089350 [Abstract] [Full Text] [Related]
3. CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry. Purkait S, Jha P, Sharma MC, Suri V, Sharma M, Kale SS, Sarkar C. Neuropathology; 2013 Aug; 33(4):405-12. PubMed ID: 23311918 [Abstract] [Full Text] [Related]
4. Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients. Ganigi PM, Santosh V, Anandh B, Chandramouli BA, Sastry Kolluri VR. Pediatr Neurosurg; 2005 Aug; 41(6):292-9. PubMed ID: 16293948 [Abstract] [Full Text] [Related]
5. Alteration of major vault protein in human glioblastoma and its relation with EGFR and PTEN status. Navarro L, Gil-Benso R, Megías J, Muñoz-Hidalgo L, San-Miguel T, Callaghan RC, González-Darder JM, López-Ginés C, Cerdá-Nicolás MJ. Neuroscience; 2015 Jun 25; 297():243-51. PubMed ID: 25869624 [Abstract] [Full Text] [Related]
6. DJ-1 expression in glioblastomas shows positive correlation with p53 expression and negative correlation with epidermal growth factor receptor amplification. Hinkle DA, Mullett SJ, Gabris BE, Hamilton RL. Neuropathology; 2011 Feb 25; 31(1):29-37. PubMed ID: 20497343 [Abstract] [Full Text] [Related]
11. The clinicopathologic values of the molecules associated with the main pathogenesis of the glioblastoma. Kim B, Myung JK, Seo JH, Park CK, Paek SH, Kim DG, Jung HW, Park SH. J Neurol Sci; 2010 Jul 15; 294(1-2):112-8. PubMed ID: 20441994 [Abstract] [Full Text] [Related]
12. Molecular genetics of radiographically defined de novo glioblastoma multiforme. Tortosa A, Ino Y, Odell N, Swilley S, Sasaki H, Louis DN, Henson JW. Neuropathol Appl Neurobiol; 2000 Dec 15; 26(6):544-52. PubMed ID: 11123721 [Abstract] [Full Text] [Related]
13. Rhabdoid glioblastoma is distinguishable from classical glioblastoma by cytogenetics and molecular genetics. Byeon SJ, Cho HJ, Baek HW, Park CK, Choi SH, Kim SH, Kim HK, Park SH. Hum Pathol; 2014 Mar 15; 45(3):611-20. PubMed ID: 24457079 [Abstract] [Full Text] [Related]
14. Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration. Ruano Y, Ribalta T, de Lope AR, Campos-Martín Y, Fiaño C, Pérez-Magán E, Hernández-Moneo JL, Mollejo M, Meléndez B. Am J Clin Pathol; 2009 Feb 15; 131(2):257-63. PubMed ID: 19141386 [Abstract] [Full Text] [Related]
15. Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas. Sung T, Miller DC, Hayes RL, Alonso M, Yee H, Newcomb EW. Brain Pathol; 2000 Apr 15; 10(2):249-59. PubMed ID: 10764044 [Abstract] [Full Text] [Related]